MAM
PNB Housing Finance Limited launches new multi-media campaign to create awareness about its Fixed Deposit Schemes
New Delhi: PNB Housing Finance Limited has launched a new multi-media, multi-city brand campaign to create awareness about benefits of its Fixed Deposit Schemes with offers on rates of interest backed with differentiated product features which may appeal to people of different ages, including senior citizens and parents of young children. The FD Schemes offer an auto renewal feature, multiple pay-out options and additional interest for senior citizens.
Rolled out across print, outdoor and digital platforms, series of advertisements showcase key attributes of the Company’s FD Scheme which are offered at a rate of interest of up to 8.45% for a tenor of 60-71 months on a minimum deposit of ₹ 10,000. The Company has rolled out FD Schemes which offer a premium or additional benefit of 0.25% in interest rate to senior citizens.
Speaking about the campaign, Mr. Shaji Varghese, the Executive Director, Business Development, said – “We believe fixed deposits should be an important component of the investment portfolio of an individual. The ₹ 20,000 crore fixed deposit programme of the Company has a credit rating of CRISIL FAAA/Negative and the ₹ 18,500 crore fixed deposit programme with a tenor of 12 months to 120 months has a credit rating of CARE AA+/Stable. Fixed deposits by our Company are offered at varied rates of interest, customized product features coupled with a customer centric delivery model that comprises of both physical branch network and technology enabled non-branch platforms such as website, mobile app etc. with self-servicing capabilities. We encourage customers to choose fixed deposits as an option which we believe may facilitate control over returns and may help them save for future.”
The advertisements have been conceptualized by the creative agency DDB Mudra Private Limited while DDB Mudramax will function as the media agency. The OOH is done by The Max. The campaign will run in Delhi NCR, Jaipur, Kolkata Chennai, Bangalore, Hyderabad, Pune, Mumbai and Ahmedabad.
Safe Harbour Statement
No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this release is only current as of its date. Certain statements made in this release may not be based on historical information or facts and may be “forward looking statements”, including those relating to the Company’s general business plans and strategy, its future financial condition and growth prospects, and future developments in its industry and its competitive and regulatory environment. Actual results may differ materially from these forward-looking statements due to a number of factors, including future changes or developments in the Company’s business, its competitive environment and political, economic, legal and social conditions in India. This communication is for general information purpose only, without regard to specific objectives, financial situations and needs of any particular person. This release does not constitute an offer or invitation to purchase or subscribe for any shares in the Company and neither any part of it shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. The Company may alter, modify or otherwise change in any manner the content of this release, without obligation to notify any person of such revision or changes. This release cannot be copied and/or disseminated in any manner.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
